American Journal of Epidemiology Vol. 116, No. 6: 878-885
Copyright © 1982 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
RETEST RELIABILITY OF PLASMA CHOLESTEROL AND TRIGLYCERIDE
THE LIPID RESEARCH CLINICS PREVALENCE STUDY
1Laboratory of Physiological Hygiene, School of Public Health, U. of Minnesota Minneapolis, MN
2Dept of Community Medicine U. of California at San Diego La Jolla, CA
Address for correspondence and reprint requests Dr Basil M Rifkind, Lipid Metabolism-Athero-genesis Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20205
Retest reliability for plasma cholesterol and triglyceride is important diagnostically and In the planning of studies. Coefficients of variation of about 8% for cholesterol and 25% for triglyceride are reported here during Visits 1 and 2 of the Lipid Research Clinics Prevalence Study in 19721975. Retest reliability showed little or no dependence on other factors studied. It would not be unusual to observe apparent cholesterol changes of 50 mg/dl and occasionally 100 mg/dl with no obvious explanation. Apparent random triglyceride changes may be as high as several hundred mg/dl. It is of clinical importance that two thirds of persons In the upper quintile of cholesterol and/or triglyceride at first measurement remain In this rank and one third rank lower on retest Multiple observations of these lipid values are recommended both for clinical use and for establishment of study baselines.
cholesterol; lipids; triglycerides
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Tirosh, A. Rudich, T. Shochat, D. Tekes-Manova, E. Israeli, Y. Henkin, I. Kochba, and I. Shai Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men Ann Intern Med, September 18, 2007; 147(6): 377 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Magkos, B. W. Patterson, and B. Mittendorfer Reproducibility of stable isotope-labeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics J. Lipid Res., May 1, 2007; 48(5): 1204 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
Asia Pacific Cohort Studies Collaboration Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region Circulation, October 26, 2004; 110(17): 2678 - 2686. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Giltay, J. M. Geleijnse, E. G. Schouten, M. B. Katan, and D. Kromhout High Stability of Markers of Cardiovascular Risk in Blood Samples Clin. Chem., April 1, 2003; 49(4): 652 - 655. [Full Text] [PDF] |
||||
![]() |
L. Arab Biomarkers of Fat and Fatty Acid Intake J. Nutr., March 1, 2003; 133(3): 925S - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Iso, Y. Naito, S. Sato, A. Kitamura, T. Okamura, T. Sankai, T. Shimamoto, M. Iida, and Y. Komachi Serum Triglycerides and Risk of Coronary Heart Disease among Japanese Men and Women Am. J. Epidemiol., March 1, 2001; 153(5): 490 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brown, B. Rosner, W. W Willett, and F. M Sacks Cholesterol-lowering effects of dietary fiber: a meta-analysis Am. J. Clinical Nutrition, January 1, 1999; 69(1): 30 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Rosenson, C. C. Tangney, and L. J. Mosca Hormone Replacement Therapy Improves Cardiovascular Risk by Lowering Plasma Viscosity in Postmenopausal Women Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1902 - 1905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gaziano, C. H. Hennekens, C. J. O'Donnell, J. L. Breslow, and J. E. Buring Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction Circulation, October 21, 1997; 96(8): 2520 - 2525. [Abstract] [Full Text] |
||||
![]() |
D. A. Pine, D. J. Madlon-Kay, and M. Sauser Effectiveness of a Nurse-Based Intervention in a Community Practice on Patients' Dietary Fat Intake and Total Serum Cholesterol Level Arch Fam Med, March 1, 1997; 6(2): 129 - 134. [Abstract] [PDF] |
||||
![]() |
D. N. Nevin, A. Zambon, C. E. Furlong, R. J. Richter, R. Humbert, J. E. Hokanson, and J. D. Brunzell Paraoxonase Genotypes, Lipoprotein Lipase Activity, and HDL Arterioscler Thromb Vasc Biol, October 1, 1996; 16(10): 1243 - 1249. [Abstract] [Full Text] |
||||
![]() |
R. G. Bakker-Arkema, M. H. Davidson, R. J. Goldstein, J. Davignon, J. L. Isaacsohn, S. R. Weiss, L. M. Keilson, W. V. Brown, V. T. Miller, L. J. Shurzinske, et al. Efficacy and Safety of a New HMG-CoA Reductase Inhibitor, Atorvastatin, in Patients With Hypertriglyceridemia JAMA, January 10, 1996; 275(2): 128 - 133. [Abstract] [PDF] |
||||
![]() |
S. A. Grover, L. Coupal, and X.-P. Hu Identifying Adults at Increased Risk of Coronary Disease: How Well Do the Current Cholesterol Guidelines Work? JAMA, September 13, 1995; 274(10): 801 - 806. [Abstract] [PDF] |
||||
![]() |
M R Law, N J Wald, T Wu, A Hackshaw, and A Bailey Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study BMJ, February 5, 1994; 308(6925): 363 - 366. [Abstract] [Full Text] |
||||
![]() |
M. H. Criqui, G. Heiss, R. Cohn, L. D. Cowan, C. M. Suchindran, S. Bangdiwala, S. Kritchevsky, D. R. Jacobs, H. K. O'Grady, and C.E. Davis Plasma Triglyceride Level and Mortality from Coronary Heart Disease N. Engl. J. Med., April 29, 1993; 328(17): 1220 - 1225. [Abstract] [Full Text] |
||||
![]() |
S. S. Gidding The Rationale for Lowering Serum Cholesterol Levels in American Children Arch Pediatr Adolesc Med, April 1, 1993; 147(4): 386 - 392. [Abstract] [PDF] |
||||
![]() |
L. Irwig, P. Glasziou, A. Wilson, and P. Macaskill Estimating an Individual's True Cholesterol Level and Response to Intervention JAMA, September 25, 1991; 266(12): 1678 - 1685. [Abstract] [PDF] |
||||
![]() |
J. M. Keenan, P. L. Fontaine, J. B. Wenz, S. Myers, Z. Huang, and C. M. Ripsin Niacin Revisited: A Randomized, Controlled Trial of Wax-Matrix Sustained-Release Niacin in Hypercholesterolemia Arch Intern Med, July 1, 1991; 151(7): 1424 - 1432. [Abstract] [PDF] |
||||
![]() |
J. W.T. Dickerson and D. Donaldson Cholesterol Screening -- Is It Desirable? Perspectives in Public Health, February 1, 1991; 111(1): 31 - 34. |
||||
![]() |
M. Mogadam, S. W. Ahmed, A. H. Mensch, and I. D. Godwin Within-Person Fluctuations of Serum Cholesterol and Lipoproteins Arch Intern Med, August 1, 1990; 150(8): 1645 - 1648. [Abstract] [PDF] |
||||
![]() |
J. L. Weissfeld, L. A. Weissfeld, J. J. Holloway, and A. M. Bernard A Mathematical Representation of the Expert Panel's Guidelines for Nigh Blood Cholesterol Case-finding and Treatment Med Decis Making, June 1, 1990; 10(2): 135 - 146. [Abstract] [PDF] |
||||
![]() |
G. Schectman and R. G. Hoffmann A History of Hypercholesterolemia Influences Cholesterol Measurements Arch Intern Med, May 1, 1988; 148(5): 1169 - 1171. [Abstract] [PDF] |
||||
![]() |
The Expert Panel, D. S. Goodman, S. B. Hulley, L. T. Clark, C. E. Davis, V. Fuster, J. C. LaRosa, A. Oberman, E. J. Schaefer, D. Steinberg, et al. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Arch Intern Med, January 1, 1988; 148(1): 36 - 69. [Abstract] [PDF] |
||||
![]() |
S. D. Fihn A Prudent Approach to Control of Cholesterol Levels JAMA, November 6, 1987; 258(17): 2416 - 2418. [Abstract] [PDF] |
||||















